Cytokinetics Inc (CYTK)

12.55
NASDAQ : Health Care
Prev Close 12.55
Day Low/High 0.00 / 0.00
52 Wk Low/High 6.54 / 13.70
Avg Volume 332.60K
Exchange NASDAQ
Shares Outstanding 41.73M
Market Cap 521.62M
EPS 0.40
P/E Ratio 32.05
Div & Yield N.A. (N.A)

Latest News

Origent Data Sciences And Cytokinetics Advance Collaboration Intended To Validate Predictive Analytics Model In ALS

Origent Data Sciences And Cytokinetics Advance Collaboration Intended To Validate Predictive Analytics Model In ALS

Research Aimed at Accelerating Conduct of Clinical Trials

Cytokinetics Announces Preclinical Data For CK-2127107 Presented At MDA Scientific Conference

Cytokinetics Announces Preclinical Data For CK-2127107 Presented At MDA Scientific Conference

Next-Generation Fast Skeletal Troponin Activator Improves Muscle Function in Mouse Models of Spinal Muscular Atrophy

These Stocks Are Trending Up With Monster Volume

These Stocks Are Trending Up With Monster Volume

Let's take a look at several stocks that are experiencing unusual volume activity.

7 Stocks Trending Up With Monster Volume

7 Stocks Trending Up With Monster Volume

Here's a technical look at how to play a number of stocks trending higher with strong volume.

Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics

Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics

Sucampo Pharmaceuticals, Intellia Therapeutics and Cytokinetics were among the biotech stock movers in premarket trading on Wednesday.

Oversold Conditions For Cytokinetics

Oversold Conditions For Cytokinetics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.

Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird

Biotech Premarket Movers: Cytokinetics, Artana Therapeutics, Bluebird

Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.

Interesting CYTK Put And Call Options For August 18th

Interesting CYTK Put And Call Options For August 18th

Investors in Cytokinetics Inc saw new options begin trading this week, for the August 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 196 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Premarket Biotech Movers: Cytokinetics, Achillion, Qiagen

Premarket Biotech Movers: Cytokinetics, Achillion, Qiagen

Cytokinetics, Achillion and Qiagen were among the biotech stock movers in premarket trading on Thursday.

Commit To Purchase Cytokinetics At $8, Earn 15.8% Annualized Using Options

Commit To Purchase Cytokinetics At $8, Earn 15.8% Annualized Using Options

Investors considering a purchase of Cytokinetics Inc stock, but cautious about paying the going market price of $10.40/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $8 strike, which has a bid at the time of this writing of $1.10.

Cytokinetics Stock Sees Short Interest Decline 11%

Cytokinetics Stock Sees Short Interest Decline 11%

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 387,607 share decrease in total short interest for Cytokinetics Inc , to 3,108,691, a decrease of 11.09% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.